🇺🇸 FDA
Patent

US 10576099

Injectable scaffold for treatment of intracranial aneurysms and related technology

granted A61KA61K31/722

Quick answer

US patent 10576099 (Injectable scaffold for treatment of intracranial aneurysms and related technology) held by Covidien LP expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Covidien LP
Grant date
Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/722